Socioeconomic Factors and Survival of Multiple Myeloma Patients

SIMPLE SUMMARY: Multiple Myeloma is the third most common hematologic malignancy. Outcomes have improved significantly, as the result of the introduction of novel agents as well as higher utilization of autologous Hematopoietic Cell Transplant. These complex treatment regimens are quite expensive an...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamoun, Kamal, Firoozmand, Amin, Caimi, Paolo, Fu, Pingfu, Cao, Shufen, Otegbeye, Folashade, Metheny, Leland, Patel, Seema, Gerson, Stanton L., Boughan, Kirsten, De Lima, Marcos, Malek, Ehsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913279/
https://www.ncbi.nlm.nih.gov/pubmed/33546206
http://dx.doi.org/10.3390/cancers13040590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913279/
https://www.ncbi.nlm.nih.gov/pubmed/33546206
http://dx.doi.org/10.3390/cancers13040590

Ejemplares similares